Form D · Other Health Care

FLUIDX MEDICAL TECHNOLOGY, INC.

Salt Lake City, UT · CIK 0001949875

Offering snapshot reported May 3, 2024 · SEC filing

Reported sold: $1.27M
Investors reported: 19
Minimum accepted: $0
First sale: Mar 22, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$345,600 → $1,268,349
Reported investors1 → 19

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 3, 2024	Amendment	$1,268,349	$922,749vs Apr 3, 2024	19	SEC filing
Apr 3, 2024	Initial	$345,600	No comparison	1	SEC filing
Mar 20, 2023	Initial	$2,355,002	No comparison	6	SEC filing
Mar 20, 2023	Initial	$3,150,482	No comparison	13	SEC filing
Mar 20, 2023	Initial	$7,557,654	No comparison	26	SEC filing

Offering details

Securities: Equity, Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-509465

Series A Preferred Stock

Source: Form D, filed May 3, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael Dake	Director
Shawn Patrick Fojtik	Director
Greg Fredde	Director
Gregory A. Fredde	Director
Karen Ginster	Director, Executive
Lawrence Kronick	Director
James Mc Guckin	Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:

2500 S. State Street, Suite D246
Salt Lake City, UT, 84115